Women's Health Policy

ABORTION IN THE U.S.

Women’s Experiences with Abortion, Access, and Concerns About Future Pregnancy

More than half (53%) of reproductive-age women living in states with abortion-provision bans say they would not know where to go or where to find information if they needed an abortion, up from 43% in 2024, according to the KFF's 2026 Women's Health Survey. Four in 10 (40%) women living in states with gestational limits between 6 and 12 weeks say the same, as do 1 in 3 (32%) reproductive-age women nationally, up from 1 in 4 (26%) in 2024. The findings come as the greater availability of medication abortion via telehealth has transformed how many women get abortions, including women living in states with bans.

CONTRACEPTIve care IN THE U.S.

Women’s Experiences with Contraception: Use, Coverage, and Preferences

More than a dozen years after the implementation of the Affordable Care Act rule requiring most plans to cover the full costs of contraceptive care, most women still don’t know about it. According to a new analysis of the 2026 KFF Women’s Health Survey, only 4 in 10 (40%) women ages 18 to 49 know that most insurance plans must pay the full cost of contraception (down slightly from 43% in 2024). Six in 10 women either think no such requirement exists (29%) or aren’t sure (31%).

SELECTED RESOURCES

featured

Women's Health Survey

The Women’s Health Survey is a series of nationally representative surveys on women’s health conducted by KFF since 2001. The survey aims to track and document women’s experiences with the health care system, access challenges and barriers to care, knowledge related to health and well-being, and differences between women by age, race/ethnicity, income level, and insurance type.

A promotional image for the the KFF Health Policy 101 Issues in Women’s Health chapter

Health Policy Issues in Women’s Health

Examine the core health coverage and access issues —shaped by federal and state policies—that affect women’s health today, including health coverage and costs, reproductive health services, maternal health, mental health, and intimate partner violence.

State Profiles for Womens Health

Explore the latest national and state-specific data and policies on women’s health. Topics include health status, insurance and Medicaid coverage, use of preventive services, sexual health, maternal and infant health, and abortion policies. Many indicators provide state-level information for women of different racial and ethnic groups.

The essentials
  • Women’s Health Insurance Coverage

    This factsheet reviews major sources of coverage for women residing in the U.S., discusses the ACA's impact on coverage, and the coverage challenges that many women continue to face.
  • Medicaid Coverage for Women

    This data note presents key data points describing the current state of the Medicaid program as it affects women, including eligibility, reproductive health, chronic conditions, and more.
  • Dobbs: What are the Implications for Racial Disparities?

    This analysis examines the implications of the Dobbs decision and state restrictions on abortion coverage for racial disparities in access to care and health outcomes.
  • State Health Facts: Women's Health Indicators

    Information on women’s health status, utilization of services, health insurance coverage, family planning and childbirth, and abortion statistics and policies.
  • Key Facts on Abortion in the United States

    This report answers some key questions about abortion in the United States and presents data collected before the overturn of Roe v. Wade.

Stay informed.

Stay informed.

Filter

101-110 of 886 results

  • State Variations in the Role of the Reproductive Health Safety Net for Contraceptive Care Among Medicaid Enrollees

    Issue Brief

    This KFF analysis uses 2023 T-MSIS Research Identifiable Files to look at where reproductive-age female Medicaid enrollees received their last contraceptive visit by state. Overall, more than four in 10 (43%) female Medicaid enrollees received their last contraceptive visit of 2023 at a safety net provider, which includes Planned Parenthood clinics, community health centers, state and local health departments, and Indian health services, but there is wide variation by state.

  • Abortion Bans May Limit Essential Medications for Women with Chronic Conditions

    Issue Brief

    This analysis uses the 2019 IBM MarketScan claims data to look at prescriptions of methotrexate and misoprostol, two drugs that can be used to terminate pregnancies, but are also used to manage chronic conditions like cancer, autoimmune diseases, and abnormal bleeding. These drugs may be restricted in response to state abortion bans, which we find will disproportionately affect women of reproductive age who make up the majority of those who rely on these drugs.

  • Coronavirus Puts a Spotlight on Paid Leave Policies

    Issue Brief

    As the COVID-19 pandemic grows, the Centers for Disease Control and Prevention (CDC) and other public health officials recommend that people who are sick should stay home. Benefits such as sick leave and family leave can help employees follow these guidelines; however, the U.S. does not have national standards on paid family or sick leave. The lack of a national policy means some employees are forced to take unpaid leave, or come to work when…

  • The HPV Vaccine: Access and Use in the U.S.

    Fact Sheet

    This factsheet discusses HPV and related cancers, use of the HPV vaccines for both females and males, and insurance coverage and access to the vaccines.

  • Over-the-Counter Oral Contraceptive Pills

    Issue Brief

    Oral contraceptives are the most commonly used method of reversible contraception in the U.S. In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.